☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Extensive
G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US
March 3, 2021
Roche's Tecentriq (atezolizumab) Receives MHLW's Approval as the First Immunotherapy for Extensive-Stage Small Cell Lung Cancer in...
August 23, 2019
Roche's Tecentriq (atezolizumab) Receives Health Canada's Approval for 1L Extensive-Stage Small Cell Lung Cancer in Adults
August 13, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.